Assessment Of The Efficacy And Safety Of Pre-Emptive Anti-Cytomegalovirus (Cmv) Therapy In Hiv-Infected Patients With Cmv Viraemia
INTERNATIONAL JOURNAL OF STD & AIDS(2015)
Hop Tenon | St Louis Hosp | Univ Paris 07
Abstract
A number of studies have demonstrated that cytomegalovirus (CMV) viraemia is a strong predictor for CMV end-organ disease (EOD) and death in HIV-infected patients. We assess the efficacy and safety of pre-emptive anti-CMV therapy (PACT) for preventing these events. We performed a retrospective study of all HIV-infected patients seen in our institution who had detectable CMV viraemia in 2007. Seventy-one patients with advanced HIV disease (median CD4 cell count=61cells/mm(3)) were studied. Sixteen patients received PACT (mainly valganciclovir). Patients who received PACT had lower CD4 cell counts and higher blood CMV DNA levels. The cumulative incidence of CMV EOD and death at one year was 44% and 21% in patients with and without PACT, respectively (p=0.013). Both PACT and high blood CMV DNA levels were significantly associated with CMV EOD and death in unadjusted analysis. In adjusted analyses, only blood CMV DNA levels remained significantly associated with the risk of CMV EOD and death, whereas PACT was associated with a non-significant trend towards reduced CMV EOD or death (hazard ratio: 0.25, p=0.13). Five patients with PACT experienced severe drug-related adverse events. In conclusion, the use of PACT in HIV-infected patients with CMV viraemia could improve outcome but is associated with significant toxicity.
MoreTranslated text
Key words
Cytomegalovirus, CMV, HIV, AIDS, opportunistic infection, pre-emptive treatment, valganciclovir, toxicity
PDF
View via Publisher
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Related Papers
The Outcome of HIV-Positive Late Presenters According to Detectable CMV DNA and Anti-CMV Treatment
Antiviral Therapy 2017
被引用9
Biology of Blood and Marrow Transplantation 2018
被引用5
Revista da Sociedade Brasileira de Medicina Tropical 2019
被引用3
Blocking Cellular N-glycosylation Suppresses Human Cytomegalovirus Entry in Human Fibroblasts.
Microbial Pathogenesis 2019
被引用6
HIV Medicine 2021
被引用3
SIDE EFFECTS OF DRUGS ANNUAL: A WORLDWIDE YEARLY SURVEY OF NEW DATA IN ADVERSE DRUG REACTIONS, VOL 38 2016
被引用2
Clinical Infectious Diseases 2023
被引用0
The Brazilian Journal of Infectious Diseases 2023
被引用1
INTERNATIONAL JOURNAL OF STD & AIDS 2024
被引用0
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn
Chat Paper
GPU is busy, summary generation fails
Rerequest